Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
02/1998
02/26/1998CA2262817A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation
02/26/1998CA2235148A1 Novel dnas and process for producing proteins by using the same
02/25/1998EP0825442A2 Morphogenic protein screening method
02/25/1998EP0825260A2 Arginase II
02/25/1998EP0825259A1 Monoclonal antibody reactive with human-origin cetp and method of quantifying human-origin cetp
02/25/1998EP0825194A2 An amide derivative of amythiamicin
02/25/1998EP0824918A1 REMEDY AND PREVENTIVE FOR DISEASES CAUSED BY NF-$g(k)B
02/25/1998EP0824910A2 Use of a Krill Enzyme for the Treatment of Dental Plaque
02/25/1998EP0824699A2 Compounds and methods for diagnosis of leishmaniasis
02/25/1998EP0824593A2 Engineering protein posttranslational modification in transgenic organisms
02/25/1998EP0824589A1 Utrophin gene promoter
02/25/1998EP0824588A1 Il-6 activity inhibitor
02/25/1998EP0824586A1 Human uridine diphosphate galactose-4-epimerase
02/25/1998EP0824583A1 Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease states
02/25/1998EP0824547A1 Anti-fungal peptides
02/25/1998EP0824546A2 Angiostatin fragments and aggregate angiostatin and methods of use
02/25/1998EP0824545A1 Peptide compositions with growth factor-like activity
02/25/1998EP0824544A1 Peptidyl compounds which inhibit metalloproteinase and tnf liberation and their therapeutic use
02/25/1998EP0824543A1 Peptide compounds which inhibit metalloproteinase and tnf liberation, and their therapeutic use
02/25/1998EP0824357A1 The use of epidermal growth factor as a gastrointestinal therapeutic agent
02/25/1998EP0824352A1 Cyclodextrin compounds and methods of making and use thereof
02/25/1998EP0824346A2 Use of sesquiterpenes for inhibiting oxidative enzymes
02/25/1998EP0721447B1 Anthracene derivatives for use as anticancer agent or dye
02/25/1998EP0711304B1 Nickel-free hemoglobin and methods for producing such hemoglobin
02/25/1998EP0590070B1 Broad spectrum antimicrobial compounds and methods of use
02/25/1998EP0563222B1 Biologically active bactericidal/permeability-increasing protein fragments
02/25/1998EP0500695B1 GnRH ANALOGS
02/25/1998CN1174575A Antithrombotic agent and anti-von willebrand factor monoclonal antibodies
02/25/1998CN1174573A Human vascular IBP-like growth factor
02/25/1998CN1174572A Human tissue inhibitor of metalloproteinase -4
02/25/1998CN1174513A Treatment of vascular thrombosis and restenosis with inhaled nitric oxide
02/25/1998CN1174512A Use of methioninase in anti-methionine and anti-homocysteine chemotherapy
02/25/1998CN1174509A Gene transfer-mediated angiogenesis therapy
02/25/1998CN1174508A Improvement in or relating to endometrial function
02/25/1998CN1174507A Antitumor agent potentiator comprising IL-6 antagonist
02/25/1998CN1174504A Piperidines, pyrrolidines and hexahydro -1H -azepines promote release of growth hormone
02/25/1998CN1174493A Amelioration of human erectile dysfunction by treatment with iNOS, and related NOS agents
02/25/1998CN1174082A Method of using active peptide in strengthening animal's immunity and as vaccine adjuvant
02/24/1998US5721354 For treatment of infections, medical diagnosis
02/24/1998US5721353 DNAs coding for LCU13 ! motilin
02/24/1998US5721351 Compositions and methods for the treatment and diagnosis of immune disorders
02/24/1998US5721349 Genetically altered mutant strain
02/24/1998US5721348 DNA encoding PH-20 proteins
02/24/1998US5721340 p53 proteins with altered tetramerization domains
02/24/1998US5721338 Inhibitors of oligosaccharyl transferase
02/24/1998US5721337 Human thymosin β15
02/24/1998US5721251 Piperidine, pyrrolidine and hexahydro-1H-azepines promote release of growth hormone
02/24/1998US5721250 Di-and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone
02/24/1998US5721244 Combination of angiotensin-converting enzyme inhibitors with calcium antagonists as well as their use in drugs
02/24/1998US5721222 Inhibitors of human leukocyte elastase
02/24/1998US5721215 Injectable therapy for control of muscle spasms and pain related to muscle spasms
02/24/1998US5721214 Inhibitors of factor Xa
02/24/1998US5721213 Peptides, active as inhibitors of platelet aggregation
02/24/1998US5721212 Peptides for heparin and low molecular weight heparin anticoagulation reversal
02/24/1998US5721211 Compositions and methods for treating small cell and nonsmall cell lung cancers
02/24/1998US5721210 Cyclic cell adhesion modulation compounds
02/24/1998US5721208 Glycopeptides a process for their preparation and their use
02/24/1998US5721207 Administering elcatonin in acceptable vehicle by intrathecal route
02/24/1998US5721206 Stimulating the eye cell growth with interferons; preventing eye disease and degradation
02/24/1998US5721122 Obtaining lymphocytes
02/24/1998US5721121 Mammalian cell culture process for producing a tumor necrosis factor receptor immunoglobulin chimeric protein
02/24/1998US5721119 Nucleic acid sequences
02/24/1998US5721110 Reacting autoimmune antigen (from genetically engineered cells) with autoimmune antibody(from test sample) to form a complex which can be identified
02/24/1998US5721108 Capable of mediating antibody-dependent cellular cytotoxicity or complement-dependent cytolysis
02/24/1998US5721107 Antibodies to G protein coupled glutamate receptors
02/24/1998US5721104 Screening assay for anti-HIV drugs
02/24/1998US5720957 Recombinant human cytomegalovirus vaccine
02/24/1998US5720955 Method of treating rheumatoid arthritis with soluble collagen
02/24/1998US5720954 Treating patient having carcinoma overexpressing her2 receptor by administering cytotoxic factor and antibody binding to receptor, which sensitizes tumor cells to said factor
02/24/1998US5720952 Administering colony stimulating factor
02/24/1998US5720937 In vivo tumor detection assay
02/24/1998CA2002208C Extraction methods for preparing thromboplastin reagents
02/23/1998CA2183901A1 Targets for therapy and diagnosis of alzheimer's disease and down syndrome in humans
02/23/1998CA2183900A1 Agents for the pre-symptomatic detection, prevention and treatment of breast cancer in humans
02/22/1998CA2213057A1 An amide derivative of amythiamicin
02/19/1998WO1998006871A1 Materials and methods relating to the diagnosis and prophylactic and therapeutic treatment of papillary renal cell carcinoma
02/19/1998WO1998006864A2 Spatial and temporal control of gene expression using a heat shock protein promoter in combination with local heat
02/19/1998WO1998006861A2 Delivery of tolerogenic antigens via edible plants or plant-derived products
02/19/1998WO1998006859A1 Human chitinase alpha and chitinase alpha-2
02/19/1998WO1998006851A2 DEFINING EPITOPES OF THE OUTER MEMBRANE PROTEIN CopB OF $i(MORAXELLA CATARRHALIS)
02/19/1998WO1998006849A1 Expression vectors, cells, and methods for preparing thrombopoietin polypeptides
02/19/1998WO1998006847A1 Human dbi/acbp-like protein
02/19/1998WO1998006846A1 Human induced tumor protein
02/19/1998WO1998006844A1 Keratinocyte growth factor-2 (kgf-2 or fibroblast growth factor-12, kgf-12)
02/19/1998WO1998006843A1 Neuritin, a neurogene
02/19/1998WO1998006842A1 Mammalian cell surface antigens; related reagents
02/19/1998WO1998006841A2 Two human nsp-like proteins
02/19/1998WO1998006840A1 Novel human glycoprotein
02/19/1998WO1998006839A1 Cd44-like protein
02/19/1998WO1998006838A1 Methods and means for modifying complement activation
02/19/1998WO1998006837A1 Phenotypic conversion of drug-resistant bacteria to drug-sensitivity
02/19/1998WO1998006830A1 Synthetic polynucleotides
02/19/1998WO1998006826A1 Dendritic cells produced in serum-free culture
02/19/1998WO1998006823A2 Cytokine-free culture of dendritic cells
02/19/1998WO1998006753A2 P53 mutant
02/19/1998WO1998006752A1 A leptin binding protein and its use in methods for diagnosing and treating abnormalities of the endogenous leptin pathway
02/19/1998WO1998006751A1 Mcp-3, rantes and mip-1alpha receptor antagonists
02/19/1998WO1998006749A2 Soluble monovalent and multivalent mhc class ii fusion proteins, and uses therefor
02/19/1998WO1998006747A2 Uses for wnt polypeptides
02/19/1998WO1998006745A1 Amino-lipopeptide antifungal agents